18(top 2%)
papers
812(top 2%)
citations
9(top 2%)
h-index
16(top 2%)
g-index
19
all documents
831
doc citations
361
citing journals

Top Articles

#TitleJournalYearCitations
1Novel mutations of the MET proto-oncogene in papillary renal carcinomasOncogene1999487
2Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year resultsUrology199691
3Imaging of Burned-out Testis TumorJournal of Ultrasound in Medicine200359
4Transobturator tape sling for female stress incontinence with polypropylene tape and outside-in procedure: Prospective study with 1 year of minimal follow-up and review of transobturator tape slingUrology200645
5Local Recurrence After Nephron-Sparing Surgery in von Hippel-Lindau DiseaseUrology200740
6Analysis of mucosal bladder leucocyte subpopulations in patients treated with intravesical Bacillus Calmette-GuerinUrological Research198931
7Primary malignant lymphoma of the urinary bladder: report of three cases and review of the literatureEuropean Radiology200027
8Evaluation of pain and catheter-related bladder discomfort relative to balloon volumes of indwelling urinary catheters: A prospective studyInvestigative and Clinical Urology201917
9Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau diseaseInternational Journal of Oncology20189
10Oddities Sporadic Neurofibroma of the Urinary Bladder. A Case ReportUrology Case Reports20177
11Involvement of PBRM1 in VHL disease‑associated clear cell renal cell carcinoma and its putative relationship with the HIF pathwayOncology Letters20215
12MR of inferior vena cava extension of a kidney angiomyolipomaEuropean Radiology20003
13Towards rational post-nephrectomy follow-up guidelines in RCCNature Reviews Clinical Oncology20153
14Leydig Cell Tumors of the Testis: An Update of the Imaging Characteristics of a Not So Rare LesionCancers20223
15genitourinary tumours, non prostate Phase III trial of sunitinib (SU) vs placebo (PBO) as adjuvant treatment for high-risk renal cell carcinoma (RCC) after nephrectomy (S-TRAC)Annals of Oncology20162
16Residents and patients benefit from surgical simulation on a live porcine model, could we consider it as ethical?Progres En Urologie20211
17Re: The Use of Early Postoperative Prostate-specific Antigen to Stratify Risk in Patients with Positive Surgical Margins After Radical ProstatectomyEuropean Urology20160
18Incidence of urological cancers in neurological patients: a review of the literature from the EAU Young Academic Urologist Functional GroupMinerva Urology and Nephrology20230